Alessio Ardizzone
Overview
Explore the profile of Alessio Ardizzone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
435
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasan A, Ardizzone A, Giosa D, Scuderi S, Calcaterra E, Esposito E, et al.
Curr Issues Mol Biol
. 2025 Feb;
47(2).
PMID: 39996791
Spinal cord injury (SCI) involves complex pathological processes that often result in significant and long-term neurological deficits. Increasingly, research has identified microRNA-21 (miR-21) as a pivotal regulator in SCI, with...
2.
Ardizzone A, Siracusa R, Capra A, Di Paola R, Esposito E, Cuzzocrea S, et al.
Obes Res Clin Pract
. 2025 Jan;
19(1):19-27.
PMID: 39884900
Background/objectives: Obesity is a major public health concern, significantly elevating the risk of developing comorbid conditions such as type 2 diabetes mellitus and cardio-vascular diseases, while also shortening life expectancy....
3.
Repici A, Capra A, Hasan A, Basilotta R, Scuderi S, Campolo M, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684698
One of the most used chemotherapy agents in clinical practice is 5-Fluorouracil (5-FU), a fluorinated pyrimidine in the category of antimetabolite agents. 5-FU is used to treat a variety of...
4.
Ardizzone A, Lanza M, Casili G, Campolo M, Paterniti I, Cuzzocrea S, et al.
Nutrients
. 2024 Dec;
16(23).
PMID: 39683646
In the original publication [...].
5.
Hasan A, Repici A, Capra A, Mannino D, Bova V, Catalfamo A, et al.
Neuropharmacology
. 2024 Nov;
264:110239.
PMID: 39608704
Spinal cord injury (SCI) leads to severe and lasting impairments in motor and sensory functions. The intense inflammatory response following SCI is a significant challenge, and autophagy has emerged as...
6.
Ardizzone A, Scuderi S, Crupi L, Campolo M, Paterniti I, Capra A, et al.
Antioxidants (Basel)
. 2024 Sep;
13(9).
PMID: 39334702
Gastroesophageal reflux disease (GERD) represents one of the most prevalent foregut illnesses, affecting a large portion of individuals worldwide. Recent research has shown that inflammatory mediators such as cytokines, chemokines,...
7.
Ardizzone A, Bulzomi M, Luca F, Silvestris N, Esposito E, Capra A
Curr Issues Mol Biol
. 2024 Sep;
46(9):9831-9843.
PMID: 39329936
Although the risk of fluoropyrimidine toxicity may be decreased by identifying poor metabolizers with a preemptive dihydropyrimidine dehydrogenase () test, following international standards, many patients with wild-type (WT) genotypes for...
8.
Repici A, Hasan A, Capra A, Scuderi S, Paterniti I, Campolo M, et al.
Mar Drugs
. 2024 Aug;
22(8).
PMID: 39195452
The term "inflammatory bowel disease" (IBD) describes a class of relapse-remitting conditions that affect the gastrointestinal (GI) tract. Among these, Crohn's disease (CD) and ulcerative colitis (UC) are two of...
9.
Scuderi S, Ardizzone A, Salako A, Panto G, Luca F, Esposito E, et al.
Cancers (Basel)
. 2024 May;
16(9).
PMID: 38730589
Brain tumors are a heterogeneous group of brain neoplasms that are highly prevalent in individuals of all ages worldwide. Within this pathological framework, the most prevalent and aggressive type of...
10.
Repici A, Capra A, Hasan A, Bulzomi M, Campolo M, Paterniti I, et al.
Int J Mol Sci
. 2024 Apr;
25(8).
PMID: 38673922
Parkinson's disease (PD) is recognized as the second most common neurodegenerative disease worldwide. Even if PD etiopathogenesis is not yet fully understood, in recent years, it has been advanced that...